Now beginning our twelfth season, Mendelspod is advancing biological discoveries and promoting translation into every day lives through online conversation directly with the heroes of the biological revolution. Whether at the bench working on the next breakthrough or at your desk funding it, tune in and stay informed. Got a story? Reach out!
External link for Mendelspod
New Harmony, Utah 84757, US
Mendelspod reposted this
Adham Jurdi was a practicing oncologist during the pandemic. He soon saw that Natera's ctDNA test was predicting what would happen with his patients several months before the scans would show anything and decided to use it across the board with his patients. Then he joined Natera to help shape the field. Listen to his interview here: https://lnkd.in/g7QGQaRD
Adham Jurdi was a practicing oncologist during the pandemic. He soon saw that Natera's ctDNA test was predicting what would happen with his patients several months before the scans would show anything and decided to use it across the board with his patients. Then he joined Natera to help shape the field. Listen to his interview here: https://lnkd.in/g7QGQaRD
The stars are aligning in Alzheimer’s research like never before. We talk with Dr. Henrik Zetterberg about the current excitement around #Alzheimer’s research on @mendelspod #biomarkers #proteomics Alamar Biosciences, Inc. https://lnkd.in/gmBygv3h
Congrats to Mara Aspinall on her gig with Illumina Ventures! Today on the show she takes us through Diagnostic Trends in 2024. Post pandemic valuations LDT regulations Genomics 3.0 Bird flu And more https://lnkd.in/gE9ZWsfg
Yuling Luo is leading his third major life science tools company, Alamar Biosciences, Inc. Alamar recently launched a new proteomics technology that brings unprecedented sensitivity and scale for applications such as #Alzheimer's and #Immunology. We talk with Yuling on today's show. https://lnkd.in/gmz69J9b
Not all prenatal screens are the same! We talk to a new entrant in the space Jennifer Hoskovec, Senior Dir of Medical Affairs at BillionToOne. https://lnkd.in/guPrAkvP
Mendelspod reposted this
New regulation of risky pathogen research is out after much scientific debate. We talk with Harvard’s Marc Lipsitch about pros and cons. https://lnkd.in/g53JZzxW
New regulation of risky pathogen research is out after much scientific debate. We talk with Harvard’s Marc Lipsitch about pros and cons. https://lnkd.in/g53JZzxW
The epigenome is more actionable than the genome, says Bret Barnes of Illumina in today's show. Free interview, but must register. (Thank you!) #epigenetics #DNAmethylation #arrays https://lnkd.in/geCuzqA5
Mendelspod reposted this
With data out on their first assay for rheumatoid arthritis, Diana Abdueva and Maggie Louie of Aqtual, Inc. discuss the exciting possibilities of liquid biopsy beyond cancer. https://lnkd.in/gzRkSB3b #liquidbiopsy #RA